A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV)
Clinical trial NCT05580692 · TERMINATED
Trial details
- NCT number
- NCT05580692
- Sponsor
- BioMarin Pharmaceutical
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-14
- Primary completion
- 2024-07-31
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.